1. Home
  2. MCS vs ENTA Comparison

MCS vs ENTA Comparison

Compare MCS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$18.61

Market Cap

590.8M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.06

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCS
ENTA
Founded
1935
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
590.8M
374.6M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
MCS
ENTA
Price
$18.61
$14.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$23.75
$20.40
AVG Volume (30 Days)
115.8K
110.5K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
1.68%
N/A
EPS Growth
N/A
29.93
EPS
0.77
N/A
Revenue
$758,458,000.00
$102,814,000.00
Revenue This Year
$12.05
$7.76
Revenue Next Year
$3.15
N/A
P/E Ratio
$24.66
N/A
Revenue Growth
3.11
16.48
52 Week Low
$12.85
$4.96
52 Week High
$19.49
$17.15

Technical Indicators

Market Signals
Indicator
MCS
ENTA
Relative Strength Index (RSI) 62.66 56.25
Support Level $14.66 $13.39
Resistance Level N/A $15.52
Average True Range (ATR) 0.52 0.76
MACD 0.10 0.19
Stochastic Oscillator 72.80 72.61

Price Performance

Historical Comparison
MCS
ENTA

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: